Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03458962 · ClinicalTrials.gov registry record
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
A clinical trial of Genetic Disease and Genetic Syndrome, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03458962: Recruiting study of Genetic Disease and Genetic Syndrome, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
NCT03458962 is a study of Genetic Disease and Genetic Syndrome that is actively recruiting participants, run by Nicklaus Children's Hospital f/k/a Miami Children's Hospital. The registered enrollment target is 1,000 participants, below the 2,528-participant average among 30 other Genetic Disease trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03458962, a study of Genetic Disease and Genetic Syndrome, is actively recruiting participants, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this collaborative research is to study human genomes in children with suspected congenital disease, multiple-congenital anomalies and/or multi-organ disease of unknown etiology by understanding the potential value of Whole Genome Sequencing (WGS) in establishing genetic diagnosis. The study will examine diagnosis rates, changes in clinical care as a result of a genetic diagnosis, health economics including potential cost-effectiveness of WGS and patient and provider experience with genomic medicine.
Primary Outcome
Total number of enrolled patients who will undergo WGS testing
Conditions Studied
Interventions
- GENETIC Genetic Enrollees
Study Locations (1)
Florida
- Nickalus Children's Hospital f/k/a Miami Children's Hospital - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2018-02-20 |
| Est. Completion | 2070-03 |
What NCT03458962 shows while recruiting
NCT03458962 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,528-participant average among 30 other Genetic Disease trials with a reported enrollment target (60% lower).
The record links to 2 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which Genetic Enrollees is the first listed.
NCT03458962 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03458962 about?
NCT03458962 is a clinical study titled "Diagnostic Odyssey: Whole Genome Sequencing (WGS)". The goal of this collaborative research is to study human genomes in children with suspected congenital disease, multiple-congenital anomalies and/or multi-organ disease of unknown etiology by understanding the potential value of Whole Genome Sequencing (WGS) in establishing genetic diagnosis. The s...
What is the current status of trial NCT03458962?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2018-02-20. Estimated completion is 2070-03.
What conditions does trial NCT03458962 study?
This clinical trial studies the following conditions: Genetic Disease, Genetic Syndrome.
What interventions are being tested in trial NCT03458962?
The interventions under investigation include: Genetic Enrollees (GENETIC).
Who is sponsoring clinical trial NCT03458962?
This trial is sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03458962 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03458962's enrollment target sits among peer trials
1,000 6th of 30 higher than 24 of 30 other Genetic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Genetic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
RECRUITING
-
Follow-up With Preimplantation Genetic Testing Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI